T cell immunity is crucial in defense against intracellular pathogens and in surveillance of tumors. The long-term goal of these studies is to understand the mechanism of T cell activation in vivo and to determine what constitutes a memory cell. Immunological memory remains one of the most fascinating but least understood aspects of the immune system. One of the major obstacles in studying T cell memory has been the inability to isolate """"""""pure"""""""" populations of in vivo selected memory cells. We have recently developed a system that overcomes this problem: We have shown that virus specific CD8+cytotoxic T lymphocytes (CTL) can persist indefinitely in vivo, and that it is possible to isolate """"""""pure"""""""" populations of these memory T cells. The objectives of the proposed research are as follows: 1.To determine the fine specificity (viral epitope) and T cell receptor (TCR) usage of the long-lived virus specific CD8+CTL. 2.To examine lymphokine production during in vivo activation of these memory CTL. 3.To determine if immunological memory is dependent on the persistence of antigen (i.e., does survival of memory CTL depend on the presence of antigen). 4.To determine the life span, antigen requirements, and lymphokine production of virus specific memory CD4+T helper cells. These studies should lead to an improved fundamental understanding of immunological memory and T cell activation in vivo. In addition, the proposed studies may have some bearing on the development of effective vaccination strategies, and on the treatment of chronic infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI030048-01
Application #
3145125
Study Section
Experimental Virology Study Section (EVR)
Project Start
1990-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Youngblood, Ben; Hale, J Scott; Kissick, Haydn T et al. (2017) Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552:404-409
Lee, Junghwa; Hashimoto, Masao; Im, Se Jin et al. (2017) Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice. J Virol 91:
Ye, Lilin; Lee, Junghwa; Xu, Lifan et al. (2017) mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses. J Virol 91:
Kamphorst, Alice O; Wieland, Andreas; Nasti, Tahseen et al. (2017) Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355:1423-1427
Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463
Araki, Koichi; Morita, Masahiro; Bederman, Annelise G et al. (2017) Translation is actively regulated during the differentiation of CD8+ effector T cells. Nat Immunol 18:1046-1057
Ahn, Eunseon; Youngblood, Ben; Lee, Junghwa et al. (2016) Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion. J Virol 90:8934-46
Im, Se Jin; Hashimoto, Masao; Gerner, Michael Y et al. (2016) Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537:417-421
Hale, J Scott; Ahmed, Rafi (2015) Memory T follicular helper CD4 T cells. Front Immunol 6:16
Bally, Alexander P R; Lu, Peiyuan; Tang, Yan et al. (2015) NF-?B regulates PD-1 expression in macrophages. J Immunol 194:4545-54

Showing the most recent 10 out of 202 publications